
Mga Drugs Private Limited
Founded in 2024 and headquartered in Haryana, India.
Founded in 2024 and headquartered in Haryana, India.
Mga Drugs Private Limited (MDPL) is a Private Limited Indian Non-Government Company incorporated in India on 27 April 2024 (One year 10 days old ). Its registered office is in Ambala, Haryana, India.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Naresh Kumar and Manik Arora serve as directors at the Company.
Ambala, Haryana, India
+91-XXXXXXXXXX
U46497HR2024PTC121070
121070
Private Limited Indian Non-Government Company
27 Apr 2024
-
-
Unlisted
Roc Delhi
Name | Designation | Appointment Date | Status |
---|---|---|---|
Naresh Kumar ![]() | Director | 27-Apr-2024 | Current |
Manik Arora ![]() | Director | 27-Apr-2024 | Current |
Enhance accessibility to Mga Drugs's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
Unlock access to Mga Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Naresh Kumar is a mutual person
Manik Arora is a mutual person
There are no open charges registered against the company as per our records.
Mga Drugs has a workforce of 0 employees as of May 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Mga Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mga Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Naresh Kumar was appointed as a Director was appointed as a Director on 27 Apr 2024 & has been associated with this company since 1 year 10 days .
Manik Arora was appointed as a Director was appointed as a Director on 27 Apr 2024 & has been associated with this company since 1 year 10 days .
Mga Drugs Private Limited was registered on 27 Apr 2024 with Roc Delhi & aged 1 year 10 days as per MCA records.
Mga Drugs Private Limited was incorporated on 27 Apr 2024.
The authorized share capital of Mga Drugs Private Limited is ₹ 1.50 M and paid-up capital is ₹ 0.10 M.
Currently 2 directors are associated with Mga Drugs Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Mga Drugs Private Limited is Plot No. 114 Near Taneja Atta Chakki Durga Nagar, City India, Ambala, Haryana, 134003.
The corporate identification number (CIN) of Mga Drugs Private Limited is U46497HR2024PTC121070 and the company number is 121070 as per Ministry of Corporate Affairs (MCA).
Search company & director profiles for free and gain access to critical business data.